Haleon plc (HLN)
USD 9.71
(-2.02%)
USD 9.71
(-2.02%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 8.41 Billion GBP | -13.78% |
| 2022 | 9.75 Billion GBP | 1590.81% |
| 2021 | 577 Million GBP | 277.12% |
| 2020 | 153 Million GBP | -49.34% |
| 2019 | 302 Million GBP | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 8.32 Billion GBP | 697.61% |
| 2024 Q1 | 1.04 Billion GBP | -87.59% |
| 2023 Q3 | 490 Million GBP | -94.77% |
| 2023 FY | 8.41 Billion GBP | -13.78% |
| 2023 Q4 | 8.41 Billion GBP | 1616.73% |
| 2023 Q1 | 684 Million USD | -93.04% |
| 2023 Q2 | 9.37 Billion GBP | 1270.61% |
| 2022 Q3 | 13.37 Billion USD | 49.92% |
| 2022 Q4 | 9.83 Billion GBP | -26.45% |
| 2022 Q2 | 8.91 Billion GBP | -1.56% |
| 2022 FY | 9.75 Billion GBP | 1590.81% |
| 2022 Q1 | 9.06 Billion GBP | 1470.19% |
| 2021 FY | 577 Million GBP | 277.12% |
| 2021 Q4 | 577 Million GBP | 0.0% |
| 2021 Q1 | 334 Million GBP | 0.0% |
| 2020 FY | 153 Million GBP | -49.34% |
| 2019 FY | 302 Million GBP | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Amneal Pharmaceuticals, Inc. | 2.65 Billion USD | -216.362% |
| Bausch Health Companies Inc. | 21.44 Billion USD | 60.767% |
| Catalent, Inc. | 4.69 Billion USD | -79.017% |
| Emergent BioSolutions Inc. | 765.8 Million USD | -998.459% |
| Elanco Animal Health Incorporated | 5.42 Billion USD | -55.146% |
| Perrigo Company plc | 3.32 Billion USD | -153.213% |
| Teva Pharmaceutical Industries Limited | 16.92 Billion USD | 50.304% |
| Zoetis Inc. | 4.76 Billion USD | -76.648% |